---All---
  • ---All---
  • Accession
  • Catalog #

AKT3 Antibody (monoclonal) (M02)Purified Mouse Monoclonal Antibody (Mab)

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
AT1104a 100 ug 400 ul 7-10 days $ 315.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

AKT3 Antibody (monoclonal) (M02) - Product info

ApplicationIF, WB
  • Applications Legend:
  • W=Western Blotting
  • IP=Immunoprecipitation
  • IHC-P=Immunohistochemistry (Paraffin)
  • IF-IC=Immunofluorescence (Immunocytochemistry)
  • F=Flow Cytometry
Primary AccessionQ9Y243
ReactivityHuman
Concentration0.3mg/ml
IsotypeIgG2a Kappa
Clone Names60000000000
Calculated MW55775 Da

AKT3 Antibody (monoclonal) (M02) - Additional info

Gene ID 10000
Other Names
DKFZP434N0250, PKBG, PRKBG, RACPKgamma, RACgamma, STK2v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma)
Target/Specificity
AKT3 (AAD29089, 100 a.a. ~ 189 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
Dilution
WB~~1:500~1000
Format
Clear, colorless solution in phosphate buffered saline, pH 7.2 .
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Precautions
AKT3 Antibody (monoclonal) (M02) is for research use only and not for use in diagnostic or therapeutic procedures.

AKT3 Antibody (monoclonal) (M02) - Related products

AM1849a: AKT3 Antibody (Ascites)

AM1849b: AKT3 Antibody

AP3468a: Phospho-AKT3-S472 Antibody

AP7030a: AKT3 Antibody (N-term)

AP7030c: AKT3 Antibody (Center)

AP7030d: AKT3 Antibody (S472)

AP7030e: AKT3 Antibody (T447)

AP7030f: AKT3 Antibody

AP8647b: AIK3 Antibody (C-term)

RI10216: AKT3 predesign siRNA

BP3468a: Phospho-AKT3-S472 Antibody Blocking Peptide

BP7030c: AKT3 Antibody (Center) Blocking Peptide

BP7030d: AKT3 Antibody (S472) Blocking Peptide

BP7030e: AKT3 Antibody (T447) Blocking Peptide

BP8647b: AIK3 Antibody (C-term) Blocking Peptide

AT1104a: AKT3 Antibody (monoclonal) (M02)

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

The protein encoded by this gene is a member of the AKT, also called PKB, serine/threonine protein kinase family. AKT kinases are known to be regulators of cell signaling in response to insulin and growth factors. They are involved in a wide variety of biological processes including cell proliferation, differentiation, apoptosis, tumorigenesis, as well as glycogen synthesis and glucose uptake. This kinase has been shown to be stimulated by platelet-derived growth factor (PDGF), insulin, and insulin-like growth factor 1 (IGF1). Alternatively splice transcript variants encoding distinct isoforms have been described.

REFERENCES

Variation at the NFATC2 Locus Increases the Risk of Thiazolinedinedione-Induced Edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) Study. Bailey SD, et al. Diabetes Care, 2010 Jul 13. PMID 20628086.Key signalling nodes in mammary gland development and cancer. Signalling downstream of PI3 kinase in mammary epithelium: a play in 3 Akts. Wickenden JA, et al. Breast Cancer Res, 2010. PMID 20398329.Energy balance, the PI3K-AKT-mTOR pathway genes, and the risk of bladder cancer. Lin J, et al. Cancer Prev Res (Phila), 2010 Apr. PMID 20354165.Mutational and immunohistochemical study of the PI3K/Akt pathway in papillary thyroid carcinoma in Greece. Sozopoulos E, et al. Endocr Pathol, 2010 Jun. PMID 20186503.Akt2 and Akt3 play a pivotal role in malignant gliomas. Mure H, et al. Neuro Oncol, 2010 Mar. PMID 20167810.